I-Klebsiella Pneumoniae (KPN), i-Acinetobacter Baumannii (Aba)kunye ne-Pseudomonas Aeruginosa (PA) ziintsholongwane ezixhaphakileyo ezikhokelela kusulelo olufunyenwe esibhedlele, olunokubangela iingxaki ezimandundu ngenxa yokunganyangeki kwamachiza amaninzi, nokunganyangeki kwi-last line-antibiotics-carbapenems.
NgokweNdaba zokuqhambuka kweSifo ze#WHO, the ukwanda kokuchongwai-hypervirulent Klebsiella pneumoniae (hvKp) uhlobo lolandelelwano (ST) 23(hvKp ST23), okoimotoEweizakhi zofuzo ezichasene ne-carbapenem antibiotics - i-carbapenemase genes, kwaxelwa ubuncinane1ilizwe kwizonke6Imimandla ye-WHO. Ukuvela kwezi zodwa ngokuxhathisa kwii-antibiotics zomgca wokugqibela-carbapenemsifuna ukuchongwa kwangoko nangokuthembekileyo ukuququzelelaolunye unyango lwe-antimicrobial.
Umthombo: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON527
I-Klebsiella Pneumoniae,Acinetobacter Baumannii kunye nePseudomonas Aeruginosa kunye neGenethi yokuChasa iziyobisi (KPC, NDM, OXA48 kunye ne-IMP) Multiplex ukusuka kwi-Macro kunye ne-Micro-Test, ayichazi kuphela i-KPN, i-Aba kunye ne-PA, kodwa iphinda ibone i-4 carbapenemase genes, ekuvavanyeni okukodwa, ukuxhobisa ngexesha elifanelekileyo kunye nolawulo lweklinikhi olufanelekileyo.
- Uvakalelo oluphezulu lwe-1000 CFU / mL;
- Multiplex kitstreamlines ukubhaqwa kokuphephaengafunekiyo iimvavanyo;
- Ihambelana ngokubanzi neenkqubo zePCR eziqhelekileyo;
| KPN | Aba | PA | I-KPC | NDM | OXA48 | IMP | |
| PPA | 100% | 100% | 98.28% | 100% | 100% | 100% | 100% |
| NPA | 97.56% | 98.57% | 97.93% | 97.66% | 97.79% | 99.42% | 98.84% |
| OPA | 98.52% | 99.01% | 98.03% | 98.52% | 98.52% | 99.51% | 99.01% |
Ixesha lokuposa: Aug-15-2024